Vivimed Labs Ltd
NSE: VIVIMEDLAB BSE: 532660
₹6.72
(4.19%)
Sun, 31 May 2026, 06:22 pm
Market Cap548.06M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KVivimed Labs Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 757.63M | 1.33B | 1.78B | 2.76B | 3.43B | 4.16B | 6.68B | 11.09B | 13.50B | 13.79B | 13.45B | 14.62B | 11.86B | 13.08B | 10.52B | 8.52B | 2.37B | 1.87B | 1.49B | 1.16B |
| Gross profit | 169.73M | 426.14M | 261.36M | 811.11M | 835.35M | 1.18B | 1.74B | 2.62B | 2.71B | 3.24B | 3.40B | 5.27B | 3.10B | 2.59B | 897.47M | 1.14B | 15.79M | -1.66B | 72.47M | -22.79M |
| Operating expenses (excl. COGS) | -37.59M | -193.90M | -17.19M | -415.01M | -295.88M | -408.66M | -703.60M | -1.40B | -1.53B | -1.69B | -1.79B | -1.82B | -1.71B | -1.55B | -1.39B | -1.08B | -276.78M | -393.48M | -492.28M | -309.09M |
| Selling/general/admin expenses, total | — | -189.80M | — | -406.44M | -294.30M | -406.51M | -689.66M | -1.36B | -1.47B | -1.62B | -1.72B | -1.76B | -1.65B | -1.48B | -1.34B | -1.04B | -275.83M | -384.88M | -202.81M | -305.74M |
| Research & development | -21.70M | -11.22M | -11.69M | -28.76M | -33.65M | -122.15M | -213.67M | -323.05M | -394.24M | -676.24M | -628.22M | -711.69M | -747.70M | -363.04M | -419.34M | -264.37M | -3.37M | -2.66M | -2.11M | -4.22M |
| Selling/general/admin expenses, other | — | -178.58M | — | -377.69M | -260.65M | -284.36M | -475.99M | -1.04B | -1.08B | -947.60M | -1.09B | -1.04B | -897.47M | -1.11B | -921.38M | -779.17M | -272.46M | -382.22M | -200.70M | -301.52M |
| Other operating expenses, total | -37.59M | -4.09M | -17.19M | -8.56M | -1.58M | -2.15M | -13.94M | -37.93M | -57.86M | -68.32M | -73.16M | -63.67M | -63.16M | -71.68M | -47.73M | -37.32M | -950.00K | -8.60M | -289.47M | -3.35M |
| Operating income | 132.14M | 232.24M | 244.17M | 396.10M | 539.47M | 770.66M | 1.04B | 1.22B | 1.18B | 1.55B | 1.61B | 3.45B | 1.39B | 1.04B | -490.98M | 59.90M | -260.99M | -2.06B | -419.81M | -331.88M |
| Non-operating income, total | -3.10M | -52.45M | -30.78M | -166.19M | -143.02M | -218.04M | -256.93M | -239.99M | -310.74M | -775.70M | -614.29M | -588.36M | -530.67M | -381.52M | -603.77M | -758.47M | -387.34M | -1.25B | -38.42M | 13.40M |
| Interest expense, net of interest capitalized | -18.84M | -46.12M | -62.48M | -172.73M | -212.28M | -206.68M | -285.20M | -504.38M | -674.63M | -861.98M | -852.55M | -704.06M | -844.38M | -721.25M | -621.59M | -560.64M | -399.85M | -362.27M | -27.34M | -29.80M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 15.75M | -6.33M | 31.69M | 6.55M | 69.26M | 2.88M | 28.27M | 264.39M | 363.89M | 86.28M | 238.26M | 115.70M | 313.71M | 339.73M | 17.82M | -197.83M | 12.51M | 5.48M | 86.42M | 43.20M |
| Non-operating interest income | — | — | 7.06M | 22.73M | 35.14M | 2.70M | 5.13M | 17.52M | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Miscellaneous non-operating expense | 15.75M | -6.33M | 24.63M | -16.18M | 34.12M | 180.00K | 23.14M | 246.87M | 363.89M | 86.28M | 238.26M | 115.32M | 313.33M | 339.73M | 17.44M | -197.83M | 12.51M | 5.48M | 86.42M | 43.20M |
| Unusual income/expense | — | — | — | — | — | -14.24M | — | — | — | — | — | — | — | — | 0 | 0 | 0 | -892.80M | -97.50M | 0 |
| Pretax income | 129.05M | 179.79M | 213.39M | 229.91M | 396.45M | 552.62M | 778.15M | 978.76M | 868.62M | 775.37M | 999.32M | 2.86B | 857.11M | 660.45M | -1.09B | -698.57M | -648.33M | -3.31B | -458.23M | -318.48M |
| Taxes | -36.36M | -44.11M | -53.87M | -36.39M | -86.34M | -64.31M | -146.78M | -142.92M | -204.68M | -54.87M | -162.59M | -725.02M | -96.21M | -86.80M | 3.60M | -20.29M | -28.17M | 21.17M | 3.77M | -1.13M |
| Non-controlling/minority interest | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 92.69M | 135.68M | 159.52M | 193.52M | 310.11M | 488.31M | 631.37M | 835.84M | 663.94M | 720.50M | 836.73M | 2.14B | 779.43M | 573.65M | -1.09B | -718.86M | -676.50M | -3.29B | -454.46M | -319.61M |
| Net income | 92.69M | 135.68M | 159.52M | 193.52M | 310.11M | 488.31M | 631.37M | 835.84M | 663.94M | 720.50M | 836.73M | 2.14B | 779.43M | 573.65M | -1.09B | -718.86M | -676.50M | -3.29B | -454.46M | -319.61M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 92.69M | 135.68M | 159.52M | 193.52M | 310.11M | 488.31M | 631.37M | 835.84M | 663.94M | 720.50M | 836.73M | 2.14B | 779.43M | 573.65M | -1.09B | -718.86M | -676.50M | -3.29B | -454.46M | -319.61M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 150.12M | 269.78M | 295.35M | 467.59M | 635.43M | 872.68M | 1.30B | 1.81B | 1.84B | 2.21B | 2.23B | 4.04B | 1.95B | 1.71B | 178.48M | 614.85M | -78.16M | -1.87B | -220.40M | -129.64M |
| EBIT | 132.14M | 232.24M | 244.17M | 396.10M | 539.47M | 770.66M | 1.04B | 1.22B | 1.18B | 1.55B | 1.61B | 3.45B | 1.39B | 1.04B | -490.98M | 59.90M | -260.99M | -2.06B | -419.81M | -331.88M |
| Total operating expenses | -625.49M | -1.10B | -1.53B | -2.37B | -2.89B | -3.39B | -5.65B | -9.87B | -12.32B | -12.24B | -11.84B | -11.17B | -10.47B | -12.03B | -11.01B | -8.46B | -2.63B | -3.93B | -1.91B | -1.49B |
| Prepaid expenses | 1.53M | 19.01M | 3.94M | 6.67M | 460.00K | 30.67M | 4.02M | — | — | — | — | 224.36M | 289.62M | 277.71M | 298.00M | 155.59M | 158.67M | 152.78M | 95.91M | 1.05M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital and operating lease obligations | 2.81M | 31.82M | 5.63M | 3.73M | 4.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.50M | 9.50M | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 53.94M | 98.31M | 121.86M | 130.33M | 161.88M | 160.46M | 154.69M | 171.98M | 254.60M | 93.71M | 106.99M | 96.35M | — | — | — | 85.95M | 116.81M | 95.15M | 90.33M | 86.20M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.37M | 315.34M | 39.02M | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 122.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | — | 0 | — | -14.95M | -20.33M | -23.78M | -75.29M | -160.22M | 0 | -116.65M | 0 | -39.47M | -3.17B | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |